Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?

被引:9
作者
Dumba, Maureen [1 ]
Khan, Sairah [2 ]
Patel, Neva [2 ,3 ]
Perry, Laura [2 ,3 ]
Malhotra, Paresh [4 ,5 ]
Perry, Richard [4 ,5 ]
Nijran, Kuldir [2 ,3 ]
Barwick, Tara [2 ]
Wallitt, Kathryn [2 ]
Win, Zarni [2 ]
机构
[1] Imperial Coll Healthcare NHS Trust, Dept Neuroradiol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Nucl Med, London, England
[3] Imperial Coll Healthcare NHS Trust, Radiol Sci Unit, London, England
[4] Imperial Coll, Div Brain Sci, London, England
[5] Imperial Coll Healthcare NHS Trust, Dept Neurol, London, England
关键词
ALZHEIMERS-DISEASE; NATIONAL INSTITUTE; PET; DIAGNOSIS; DEMENTIA; FDG; ANGIOPATHY;
D O I
10.1259/bjr.20181027
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The number of people living with dementia is increasing, but as yet there remains no cure or disease-modifying treatment. This review aims to help readers understand the role of F-18-FDG PET/CT imaging in the investigation of cognitive impairment and how the advent of amyloid PET/CT imaging may hold the key to radically changing management of the most common form of dementia - Alzheimer's disease. The indications for F-18-FDG PET/CT and amyloid PET/CT imaging in cognitive impairment are outlined. Additionally, the mechanisms of action, technique, patient preparation and acquisition parameters for both are detailed. We conclude by providing a framework for interpreting F-18-FDG PET/CT and amyloid PET/CT imaging in the more common conditions that lead to cognitive impairment conditions with tips on avoiding pitfalls in interpretation.
引用
收藏
页数:11
相关论文
共 24 条
[1]   Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010 [J].
Beach, Thomas G. ;
Monsell, Sarah E. ;
Phillips, Leslie E. ;
Kukull, Walter .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (04) :266-273
[2]   Inequalities in dementia care across Europe: key findings of the Facing Dementia Survey [J].
Bond, J ;
Stave, C ;
Sganga, A ;
O'Connell, B ;
Stanley, RL .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 :8-14
[3]   Clinical PET/MRI: 2018 Update [J].
Broski, Stephen M. ;
Goenka, Ajit H. ;
Kemp, Bradley J. ;
Johnson, Geoffrey B. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) :295-313
[4]   Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism [J].
Brown, Richard K. J. ;
Bohnen, Nicolaas I. ;
Wong, Ka Kit ;
Minoshima, Satoshi ;
Frey, Kirk A. .
RADIOGRAPHICS, 2014, 34 (03) :684-701
[5]   Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance [J].
Charidimou, Andreas ;
Farid, Karim ;
Tsai, Hsin-Hsi ;
Tsai, Li-Kai ;
Yen, Rouh-Fang ;
Baron, Jean-Claude .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (04) :410-417
[6]   Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue [J].
Choi, Seok Rye ;
Schneider, Julie A. ;
Bennett, David A. ;
Beach, Thomas G. ;
Bedell, Barry J. ;
Zehntner, Simone P. ;
Krautkramer, Michael J. ;
Kung, Hank F. ;
Skovronsky, Daniel M. ;
Hefti, Franz ;
Clark, Christopher M. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2012, 26 (01) :8-16
[7]   Posterior cortical atrophy [J].
Crutch, Sebastian J. ;
Lehmann, Manja ;
Schott, Jonathan M. ;
Rabinovici, Gil D. ;
Rossor, Martin N. ;
Fox, Nick C. .
LANCET NEUROLOGY, 2012, 11 (02) :170-178
[8]  
Cummings Jeffrey, 2017, Alzheimers Dement (N Y), V3, P367, DOI 10.1016/j.trci.2017.05.002
[9]   Alzheimer's disease diagnostic criteria: practical applications [J].
Cummings, Jeffrey .
ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (05)
[10]   Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update [J].
Farid, Karim ;
Charidimou, Andreas ;
Baron, Jean-Claude .
NEUROIMAGE-CLINICAL, 2017, 15 :247-263